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Membrane type 1 matrix metalloproteinase is a mem-
ber of the membrane-anchored matrix metallo-
proteinase family and is involved in tissue remodeling
events ranging from tumor invasion and angiogenesis
to growth and development. We sought to clarify the
role of membrane type 1 matrix metalloproteinase in
cutaneous epidermal cells using anti-sense cDNA
expression in human keratinocytes. Modulation of
membrane type 1 matrix metalloproteinase transcript
and protein levels was achieved via retroviral expres-
sion of a 5¢ 1.4 kb anti-sense membrane type 1 matrix
metalloproteinase construct and a 3.4 kb full-length
sense membrane type 1 matrix metalloproteinase
construct in primary and immortalized keratinocytes
and SCC-25 cells. Maximal reductions were observed
48±72 h after transduction with 1.4 kb anti-sense
membrane type 1 matrix metalloproteinase construct
that correlated with signi®cant decreased pro-matrix
metalloproteinase-2 activation. Functionally, we
found decreased cell migration, reduced cellular pro-
liferation, and increased apoptotic nuclear fragmenta-
tion after 1.4 kb anti-sense membrane type 1 matrix
metalloproteinase construct expression. Our ®ndings
suggest a role for membrane type 1 matrix metallo-
proteinase in human cutaneous epidermal cell inva-
sion and survival mechanisms in vivo. Key words: cell
survival/migration/matrix metalloprotinase-2/membrane
type 1 matrix metalloproteinase. J Invest Dermatol 118:573±
581, 2002
C
ell-mediated remodeling events of the extracellular
matrix (ECM) during tissue development, wound
healing, and tumor invasion requires extracellular
proteinases that either process or degrade the ECM in
both the epithelial and interstitial compartments
(Werb, 1997). Selective breakdown of the ECM is necessary
during tissue repair, morphogenesis, and angiogenesis (Birkedal-
Hansen, 1995; Parks, 1999). Excessive destruction of the ECM is
often seen in pathologic conditions such as rheumatoid arthritis,
autoimmune blistering diseases, and tumor invasion (Kahari and
Saarialho-Kere, 1999). During normal wound healing, members of
the zinc-containing matrix metalloproteinase family (MMP) have
emerged as important epidermal regulators of tissue remodeling
(Westermarck and Kahari, 1999). Recent studies have associated
high expression of MMP with impaired wound healing and
invasive phenotype of tumors (Bullen et al, 1995; Wysocki et al,
1999). In addition, MMP may promote angiogenesis (Brooks et al,
1996, 1998) and cause genetic instability in tumor cells (Sternlicht
et al, 1999).
Among the MMP family members, MMP-2 and MMP-9 are
thought to regulate cell migration and proliferation during cancer
cell invasion, basement remodeling, and wound healing (Birkedal-
Hanson et al, 1993; Stetler-Stevenson et al, 1993; Curran and
Murray, 1999). MMP-2 is secreted in a latent form and activation
of this latent enzyme is controlled by cleavage of the N-terminal
prodomain. Several proteinases are capable of activating pro-
MMP-2, but a recently characterized subfamily of membrane-
anchored matrix metalloproteinases (MT-MMP) have been shown
to catalyze this process ef®ciently (Kinoshita et al, 1998). Activation
of pro-MMP-2 is a two-step process. It involves binding of pro-
MMP-2 to a TIMP (tissue inhibitor of MMP)-2/MT1-MMP
receptor complex on the cell surface through interaction between
the C-terminal domain of pro-MMP-2 and the C-terminal domain
of TIMP-2 (Strongin et al, 1995; Zucker et al, 1998). Thus, a
trimolecular complex is established consisting of MT1-MMP/
TIMP-2/pro-MMP-2. Further processing of pro-MMP-2 is
initiated by a free MT1-MMP molecule by cleaving the N-
terminal propeptide (Butler et al, 1998). The processing of MMP-2
by MT1-MMP generates the intermediate MMP-2 form that binds
in a second step to integrin avb3 via its C terminus (Deryugina et
al, 2000). Recent evidence suggests that the binding to integrin
avb3 contributes to autocatalytic maturation and expression of
functionally active MMP-2 on the cell surface (Brooks et al, 1998;
Deryugina et al, 2000).
MT1-MMP is known to be involved in a variety of tissue
remodeling events ranging from tumor invasion and angiogenesis
to growth and development (Sato et al, 1994; Okada et al, 1997;
Hiraoka et al, 1998; Belien et al, 1999; Holmbeck et al, 1999; Zhou
et al, 2000). Whereas expression of MT-MMP has been
characterized in ®broblasts, endothelial cells, and tumors its
expression by human epidermis has not been well studied (Okada
et al, 1997; Madlener et al, 1998; Sato et al, 1999). Notably, the role
of MT1-MMP is not restricted to pro-MMP-2 activation as it is
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also capable of degrading a number of ECM components, including
®bronectin, vitronectin, and ®brillar collagens (Pei and Weiss,
1996; Ohuchi et al, 1997).
In this study, we characterized the effects of anti-sense MT1-
MMP gene expression in normal human keratinocytes (NHK),
human papillomavirus E6/E7-immortalized human keratinocytes
(NIK), and SCC-25 tumor cells. Retroviral constructs bearing a 5¢
1.6 kb anti-sense construct (MT1-as) were used to create blockade
of MT1-MMP expression in these cells. Analysis of transduced cells
revealed reduction of both MT1-MMP protein and mRNA
expression. Importantly, inhibition of MT1-MMP via MT1-as
transduction also blocked activation of pro-MMP-2, thereby
implicating that the activity of MMP-2 is, in part, dependent on
MT1-MMP's ability to catalyze pro-MMP-2 activation. This study
also reports that MT1-as transduction decreased keratinocyte
movement through the ECM and correlated with decreased cell
survival. These ®ndings suggest that MT1-MMP plays an important
part in human epidermal cell invasion and survival processes.
MATERIALS AND METHODS
Cell lines and cell culture Primary normal NHK were isolated from
neonatal foreskin and grown as previously described by Rheinwald and
Green (1975). Keratinocytes were cultured in growth media consisting of
50% serum-free medium plus supplements (Gibco, Grand Island, NY),
50% Medium154 plus supplements (Cascade Biologics, Portland, OR),
0.05 ng amphotericin per ml, and 0.05 mg gentamycin per ml. Cells
were incubated at 37°C in 5% CO2 air atmosphere. Immortalized
keratinocyte cell line (NIK) was established from primary NHK from
neonatal foreskin by transfecting with human papillomavirus E6/E7
plasmid (SVE NEO Bal E6/E7 18 CCB). The cells continued to be
grown in media consisting of 50% serum-free medium plus supplements
(Gibco), 50% Medium154 plus supplements (Cascade Biologics) with
0.05 ng amphotericin per ml, and 0.05 mg gentamycin per ml. Cells
were incubated at 37°C in 5% CO2 air atmosphere. The cell line was
expanded for approximately 12±15 more passages. SCC-25 from
humans, a squamous cell carcinoma from tongue is a tumorigenic cell
line from ATCC. The cell line was propagated in media consisting of
50% serum-free medium plus supplements (Gibco), 50% Medium154
plus supplements (Cascade Biologics) with 0.05 ng amphotericin per ml,
and 0.05 mg gentamycin per ml. Cells were incubated at 37°C in 5%
CO2 air atmosphere.
Gene transduction Human MT1-MMP cDNA (a kind donation from
Motoharu Seiki), sequence encoding the open reading frame from amino
acids 1±1600 was subcloned into the EcoR1 and BamH1 site of the
LZRS retroviral vector to obtain MT1-as construct. LzrsMT1-MMP
sense construct (MT1-s) was obtained by subcloning the 3.4 kb MT1-
MMP cDNA into the EcoR1 site of the LZRS retroviral vector.
Amphoteric retrovirus production and gene transfer to passage one
primary keratinocytes (NHK), NIK, and SCC-25 cells was performed as
previously described (Choate et al, 1996; Kinsella and Nolan, 1996).
Mock (enhanced green ¯uorescent protein reporter gene) construct was
used for mock transduction. Brie¯y, 40±50% con¯uent cells were
overlaid with retroviral supernatant with polybrene and centrifuged at
300 3 g for 1 h. Cells were incubated for 4±6 h and changed to fresh
medium. Forty-eight and 72 h later, cells were analyzed.
Western blot analysis Cells were lyzed in RIPA lysis buffer (50 mM
Tris±Cl, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate,
1% Nonidet P-40 and 150 mM NaCl) containing protease inhibitors
(Sigma-Aldrich, St. Louis, MO). Lysates were pelleted to remove debris,
and the protein was quantitated using Coomassie Plus protein assay
reagent (Pierce, Rockford, IL). Twenty micrograms of protein per
sample was denatured in equal amounts of 2 3 Laemmli sample buffer
containing 10% b-mercaptoethanol and was resolved on a 10% SDS±
polyacrylamide gel. Gels were transferred to nitrocellulose membranes
(Bio-Rad Laboratories, Hercules, CA). Membranes were blocked with
5% milk in Tris-buffered saline containing 0.5% Tween-20 for 1±2 h.
Polyclonal anti-MT1-MMP was purchased from Chemicon (Temecula,
CA) and was used at a dilution of 1:2000. Monoclonal antibody for
b-actin was used (Chemicon) to verify equal protein loading per lane.
Secondary antibody (donkey anti-rabbit, sheep anti-mouse, horseradish
peroxidase-conjugated; Amersham Corp., Piscataway, NJ) was used at
1:5000 and 1:2500. Enhanced chemiluminescence detection was
performed as per the manufacturer's instructions (Amersham).
Gelatin zymography Conditioned media collected after 48 and 72 h
after transduction, was concentrated 40 3 and protein was quantitated
using Coomassie Plus protein assay reagent (Pierce). One microgram of
protein per sample was prepared in 4 3 loading buffer (1% SDS, 0.4 g
sucrose, 10 mg bromophenol blue, in 0.5 M Tris±Cl buffer, pH 6.8) and
size fractionated on a 10% SDS±polyacrylamide gel containing 3 mg per
ml gelatin. The gels were then washed in 2.5% Triton X-100 (2 3) for
30 min to remove SDS, washed with water and incubated overnight in
metalloproteinase substrate buffer (50 mM Tris±Cl, pH 8.0, 5 mM
CaCl2). Gels were stained with Coomassie blue (50% methanol and 10%
acetic acid containing 0.25% Coomassie blue R250) for 2 h. Gelatinase
activity appeared as clear bands. Gels were scanned using Gel Doc 1000
Gel Documentation system (BIO-RAD) and band intensities were
calculated with Kodak ID 2.02 image analysis software.
Immunohistochemical assays Transduced and nontransduced cells
were grown on glass slides to 40±60% con¯uence. Cells were ®xed with
3 M Glycine. 0.9%NaCl, pH 3.0 for 3 min and then blocked with 0.5%
bovine serum albumin in phosphate-buffered saline for 30 min. Slides
were incubated with MT1-MMP monoclonal antibody (Ab-4;
Calbiochem-Novabiochem Corp., La Jolla, CA) at 20 mg per ml. Slides
were stained with anti-mouse IgG Cy3 conjugate (Sigma) at 1:200
dilution and subjected to immuno¯uorescence analysis. Control slides
incubated with mouse IgG at 20 mg per ml and stained with anti-mouse
IgG Cy3 conjugate was used as a measure of background nonspeci®c
¯uorescence.
Fluorescence in situ hybridization Cells were cultured on poly L-
lysine coated chamber slides to 50±70% con¯uence. Cells were ®xed
with 4% formaldehyde, 5% acetic acid, and 0.9% NaCl. The ®xed cells
were dehydrated and treated with 0.1% pepsin (Roche Molecular
Biochemicals, Roche Applied Science, Indianapolis, IN) in 0.1 M HCl.
The cells were post ®xed with 1% formaldehyde. Single strand sense and
anti-sense denatured RNA probes of MT1-MMP prepared and labeled
with digoxigenin-deoxyuridine triphosphate (Roche Molecular
Biochemicals) with MAXIscript In Vitro Transcription kit (Ambion,
Inc., Austin, TX). The cells were hybridized at 50°C overnight in 10 ml
of 60% deionized formamide, 300 mM NaCl, 30 mM sodium citrate,
10 mM ethylenediamine tetraacetic acid, 25 mM NaH2PO4 (pH 7.4),
5% dextran sulfate, and 250 ng per ml sheared salmon sperm DNA
containing 5 ng per ml of denatured probe. After hybridization the slides
were washed once at room temperature with 2 3 sodium citrate/
chloride buffer, 50% formamide, two times with 2 3 sodium citrate/
chloride buffer, 50% formamide at 50°C and twice with 1 3 sodium
citrate/chloride buffer, 50% formamide at room temperature. Cells were
then subjected to immuno¯uorescent detection by incubating in anti-
digoxigenin-¯uorescein (1:500) antibody to detect the hybridized
digoxigenin-labeled probe. The slides were washed with a solution of
100 mM Tris±HCl, pH 7.5; 150 mM NaCl, 0.05% Tween-20. The cells
were embedded in DABCO (anti-fading solution) and counterstained
with propidium iodide for DNA (Roche Molecular Biochemicals). The
¯uorescence in situ hybridization images were captured with a Lecia
confocal ¯uorescence microscope.
Migration assays Cellular invasion was studied in modi®ed Boyden
chambers. Migration assays were performed in Transwell chambers
(Costar, Transwell Plate, American Scienti®c and Industrial Supplies,
Radnor, PA). An upper surface of 8 mm polycarbonate membrane was
coated with 5 mg per ml of Vitrogen 100 (Collagen Biomaterials, Palo
Alto, CA), 10 mg ®bronectin per ml (Chemicon, Temechula, CA) for
1 h at 37°C. The lower compartments of the 24-well chemotactic
Boyden chamber were ®lled with 200 ml medium. Cells were suspended
in medium and seeded at 50,000 cells per well in the upper
compartment of the chamber. After 16 h of incubation at 37°C, cells
that migrated on to the lower surface of the ®lters were ®xed in 3%
formaldehyde and stained with 0.1% crystal violet and counted in ®ve to
eight randomly selected ®elds for each chamber well with a Zeiss
Axioscope connected to a CCD camera. All experiments were
performed in triplicate.
Cell death enzyme-linked immunosorbent assay Cells were
cultured in six-well plates and after 48 and 72 h of transduction, cells
were harvested and the assay was performed according to the
manufacturer's instructions (Roche Molecular Biochemicals). Brie¯y,
plates were centrifuged for 10 min at 200 3 g, and supernatants were
removed. Cells were then removed and lyzed for 30 min at room
temperature, and plates were centrifuged again. Ten percent (vol/vol) of
the supernatant was used for incubation with anti-histone±biotin and
anti-DNA peroxidase. After 2 h of incubation, plates were washed three
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times and incubated with substrate solution. The absorbance was
measured at 405 nm with a microplate reader (BIO-RAD).
Cell proliferation assay CellTiter 96 AQueousOne Solution Cell
Proliferation Assay (Promega, Madison, WI), a colorimetric method was
used for determining the number of viable cells in proliferation assays.
Brie¯y, cells were harvested and resuspended in medium and 50 ml of
cell suspension (50,000 cells) were added into each well in a 96-well
plate; the plates were incubated overnight at 37°C. Assays are performed
by adding a 20 ml of the CellTiter 96 AQueousOne Solution reagent
directly to the cells, incubating 1±4 h, and recording absorbance at
450 nm with a 96-well plate reader. The reagent contains MTS
tetrazolium compound, which is bioreduced by cells into a colored
formazan product. The corrected absorbance at 450 nm (y-axis) vs time
was plotted to determine the viable cell number.
RESULTS
MT1-as cells show a signi®cant decrease in cell associated
MT1-MMP expression We constructed two recombinant
retroviral vectors, LzrsMT1-MMP sense and MT1-as containing
sequences from human MT1-MMP cloned in the sense and anti-
sense orientation. To test the ability of MT1-as to attenuate MT1-
MMP protein expression, we produced virons and infected NHK,
NIK, and SCC-25 cells. Forty-eight and 72 h later, cells were
examined for MT1-MMP transcript by ¯uorescence in situ
hybridization. Pilot time course experiments showed these times
to be optimal in terms of attenuating target MT1-MMP gene
expression. We found the levels of MT1-MMP transcripts were
markedly reduced in MT1-as transduced NHK and NIK at 48 h
(see Fig 1) relative to controls, and was further decreased at 72 h of
transduction (data not shown). Cells infected with MT1-as also
expressed the appropriate 1.4 kb anti-sense RNA transcript, as
detected by northern blotting (data not shown). Similar results were
observed in SCC-25 and thus, the vector MT1-as attenuated MT1-
MMP gene expression in all three epidermal cell types tested.
To verify in situ analysis at the cellular level, immuno¯uorescent
staining for MT1-MMP in cells infected with MT1-as was also
reduced relative to controls (see Fig 2).
Expression of MT1-as speci®cally, but not MT1-s or mock
resulted in consistent decreases in protein expression as seen by
immunoblotting after 48 h of infection (see Fig 3). No signi®cant
changes in Mt3-MMP protein levels were seen (data not shown).
NHK, NIK, and SCC-25 cells transduced with MT1-s construct
had levels that were comparable with nontransduced (control) and
mock-transduced cells.
Together, our results indicate MT1-as transduction in primary
and transformed human keratinocytes is an effective method for
transiently blocking the expression of MT1-MMP.
MT1-as cells inhibit activation of pro-gelatinase A (pro-
MMP-2) As pro-MMP-2 is a major functional target for MT1-
MMP activity we determined the effect of MT1-as on pro-MMP-2
activation in NHK, NIK, and SCC-25 cells. As shown in Fig 4(A±
C), MMP-2 activity was decreased in all cells expressing MT1-as.
Densitometric analysis of gelatin zymograms showed active MMP-
2 band in MT1-s lane was approximately 4-fold more than MT1-as
lane in NHK cells at 48 h and approximately 23-fold more at 72 h
after transduction (see Fig 4A). Similarly, the intensity of active
MMP-2 band in the MT1-s lane was approximately 2.5±3-fold
more than MT1-as lane in NIK and SCC-25 (Fig 4B, C) cells at
48 h and 72 h after transduction.
Invasive properties of MT1-as transduced NHK, NIK cells,
and SCC-25 cells is attenuated by MT1-a Cell migration is
an essential process requiring MMP activity and the proteolytic
potential of MMP have been correlated with the metastatic
capacity of many different tumor cell types (Birkedal-Hanson et
Figure 1. In situ hybridization of keratinocyte MT1-MMP transcripts. Cells transduced with MT1-as were grown on chamber slides and
probed with FITC-labeled MT1-MMP anti-sense and sense RNA probe. The levels of MT1-MMP transcripts show a decrease in MT1-as transduced
cells after 48 h of infection as compared with control and mock-transduced cells when probed with the anti-sense probe. The sense probe gave only a
background signal in control and mock-transduced cells (data not shown), whereas a strong signal for MT1-as transcript was seen relative to controls
and was further decreased at 72 h of transduction (data not shown).
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al, 1993; Stetler-Stevenson et al, 1993; Curran and Murray,
1999). As MT1-MMP activation of pro-MMP-2 is critical for
tumor cell invasion (Sato et al, 1994) we sought to examine the
role of MT1-MMP in keratinocyte migration. NHK, NIK, and
SCC-25 cells transduced with MT1-as and MT1-s were
analyzed for migration using collagen and ®bronectin-coated
Boyden chamber plates. Figure 5 shows a 2-fold increase in
migration in MT1-s-transduced NHK, NIK, and SCC-25 cells
relative to MT1-as similar to previous studies with tumor cells
(Sato et al, 1994). Our data therefore suggests that MT1-as
expression affects both the expression and the functional activity
of its target gene. The invasive properties of NHK, NIK, and
SCC-25 cells is attenuated by MT1-as.
Our results suggest MT1-MMP expression facilitates migration
of human keratinocytes in collagen and ®bronectin matrices.
Whether the activity of MT1-MMP is directly involved in
keratinocyte migration or indirectly via pro-MMP-2 activation
remains to be shown.
Figure 2. Immuno¯uorescence of MT1-MMP protein expression. Cells transduced with MT1-as and MT1-s constructs were grown on chamber
slides, and ®xed with 3 M glycine, 0.9% NaCl, pH 3.0 for 3 min and then blocked with 0.5% bovine serum albumin in phosphate-buffered saline for
30 min. Slides were incubated with MT1-MMP monoclonal antibody (Ab-4, Calbiochem) at 20 mg per ml. MT1-as-transduced cells show a signi®cant
decrease in cell associated MT1-MMP expression as compared with control, and MT1-s- and mock-transduced cells after 48 h of infection.
Figure 3. Western blots of cellular MT1-MMP. Total cell lysates were loaded into each lane and probed with MT1-MMP rabbit polyclonal
antibody. Lane 1: control (nontransduced cells). Lane 2: cells transduced with sense construct (MT1-s). Lane 3: cells transduced with anti-sense
construct (MT1-as). Lane 4: cells transduced with mock construct. b-actin was used as an internal control. MT1-as-transduced cells (lane 3, anti-sense)
show a signi®cant decrease in cell-associated MT1-MMP expression as compared with controls (lane 1), MT1-s-transduced cells (lane 2), and mock-
transduced cells (lane 4) after 48 h of infection.
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MT1-as expression correlates with high apoptotic nuclear
fragmentation and cell proliferation arrest To explore
further the effects of MT1-MMP anti-sense expression in NHK,
NIK, and SCC-25 we analyzed cytoplasmic samples of transduced
cells at 48 and 72 h postinfection for histone-associated DNA
fragments that associate with apoptotic internucleosomal
degradation of genomic DNA. As shown in Fig 6, a 2-fold
increase in apoptotic nuclear fragmentation was observed in MT1-
as in NHK, NIK, and SCC-25 transduced cells as compared with
nontransduced cells at 72 h after transduction.
Consistent with the hypothesis that cell survival may be affected
by MT1-MMP expression, we also found a decrease in the number
of viable cells in all three cell types transduced by MT1-as after 72 h
of infection (Fig 6A-b, B-b, C-b). No signi®cant effect on
Figure 4. Zymographic analysis of pro-MMP-2 activation in
conditioned media. (A) NHK cells were transduced with MT1-s,
mock, and MT1-as constructs. Conditioned media was collected after
48 h and 72 h after transduction and analyzed by gelatin zymography.
Quantitative results of zymograms were obtained by densitometry of the
gels. Results represent the mean 6 SD of two separate zymograms.
Relative changes in pro-MMP-2 activation were calculated based on
densitometry. An increase in activation was observed in MT1-s-
transduced cells, whereas MT1-as-transduced cells showed a decrease in
pro-MMP-2 activation as compared with control and mock-transduced
cells. *p < 0.05 compared with mock-transduced cells. No signi®cant
difference was observed in the active MMP-2 band in control cells
(nontransduced cells and mock-transduced cells). The intensity of the
active MMP-2 band in control cells was approximately 3.5-fold higher
than the MT1-as lane in NHK cells at 48 h after transduction.
Furthermore, analysis of the conditioned media from NIK and SCC-25
cells also showed that MMP-2 activity was inhibited in MT1-as
expressing cells (see B and C). Conversely, overexpression of MT1-
MMP via LzrsMT1-MMP sense induces pro-MMP-2 activation. The
MMP-2 activity in MT1-s was approximately 6±7-fold more than MT1-
as in NIK cells at 48 h and 72 h after transduction. (B) NIK were
transduced with MT1-s, mock, and MT1-as constructs. Conditioned
media was collected after 48 h and 72 h after transduction and analyzed
by gelatin zymography. Quantitative results of zymograms were obtained
by densitometry of the gels. Results represent the mean 6 SD of two
separate zymograms. Relative changes in pro-MMP-2 activation were
calculated based on densitometry. *p < 0.05 compared with mock-
transduced cells. (C) SCC-25 cells were transduced with MT1-s, mock,
and MT1-as constructs and conditioned media analyzed as described for
NHK and NIK. *p < 0.05 compared with mock-transduced cells.
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Figure 5. Boyden chamber analysis of cellular invasion through collagen and ®bronectin. NHK (A), NIK (B), and SCC-25 (C) cells were
transduced with MT1-s and MT1-as constructs and 48 h and 72 h after transduction cells were analyzed for migration. Cells were also mock
transduced with a mock vector. Results represent the mean 6 SD of four separate experiments. Each bar represents the mean 6 SD for cell migration
of ®ve wells. An increase in migration was observed in MT1-s-transduced cells, whereas MT1-as-transduced cells showed a decrease in migration as
compared with control and mock-transduced cells on collagen and ®bronectin in all three cell types. *p < 0.05 compared with mock-transduced cells.
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Figure 6. DNA nuclear fragmentation and cell survival analysis. Basal level of apoptotic nuclear fragmentation in NHK (A-a), NIK (B-a), and
SCC-25 (C-a) showed cells transduced with MT1-as had signi®cantly higher internucleosomal DNA-histone fragment signals as compared with MT1-s,
mock, and control cells. A decrease in the number of viable cells measured by the NHK (A-b), NIK (B-b), and SCC-25 (C-b) cells transduced by MT1-
as as measured by a cell proliferation assay. Results represent the mean 6 SD of four separate experiments. *p < 0.05 compared with mock-transduced
cells.
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keratinocyte growth was observed during the 48 and 72 h period in
mock-transduced or nontransduced control cells, whereas,
LzrsMT1-MMP sense expression was associated with the highest
survival levels in all three cell types. These results suggest that
suppressing MT1-MMP expression may induce apoptosis, leading
to keratinocyte proliferation arrest and decreases in survival.
DISCUSSION
Cutaneous wound repair depends on cell migration and ECM
remodeling. Both processes, which are necessary for re-epitheliza-
tion and restoration of the underlying connective tissue, involve the
action of extracellular proteinases. The complex interactions
between keratinocytes and MMP and their role in tissue remodel-
ing are not fully understood. We have previously observed that in
human skin endothelial cells, antibodies to MT1-MMP can
modulate pro-MMP-2 activation and attenuate the morphogenetic
pattern of tubule formation in three-dimensional collagen gel
(Chan et al, 1998). MT1-MMP-de®cient mice exhibit severe
defects in skeletal development but were viable and could not be
distinguished phenotypically from wild-type or heterozygous
littermates at birth except for a slightly domed-shaped skull and a
short snout (Holmbeck et al, 1999; Zhou et al, 2000). Whereas no
developmental abnormalities were reported in the skin of MT1-
MMP null mice, it is possible that wounding or tumor implantation
studies may have revealed fundamental defects in cutaneous ECM
metabolism. Furthermore, no studies were performed on epidermal
cells derived from the skin of these mice to rule-out altered
functionality. As little information is known about MT1-MMP
expression in the epidermis (Madlener et al, 1998; Sato et al, 1999;
Baumann et al, 2000) we initiated studies to help de®ne its role in
human keratinocytes. Initially, we found that MT1-MMP was
constitutively expressed in NHK isolated from neonatal skin and
used the retroviral anti-sense vector, MT1-as, to attenuate target
MT1-MMP mRNA and protein expression in NHK, NIK, and
SCC-25 cells (Figs 1±3).
Our observation that MT1-MMP transcript is expressed by
human keratinocytes (Fig 1A) suggests that pro-MMP2 may be
activated by MT1-MMP in human epidermis, at least in vitro. We
found that MMP-2 activity was suppressed by MT1-as transduc-
tion, suggesting that the activity of MMP-2 may be dependent on
MT1-MMP's ability to catalyze pro-MMP2 activation (Fig 4A±C)
in human keratinocytes. Recent studies have shown that MT1-
MMP and avb3 functionally cooperate to activate pro-MMP-2 to
its fully mature form (Brooks et al, 1996, 1998). Expression of
integrin avb3 correlates with activation of MT1-MMP and MMP-
2 and is associated with increased cell motility and activation of
MMP-2 (Deryugina et al, 2000; Hofmann et al, 2000). A direct role
for MT1-MMP in the activation of pro-MMP-2 produced by
endothelial cells in three-dimensional collagen gels has also been
shown (Haas et al, 1998) and overexpression of MT1-MMP
increases cell invasiveness by activating MMP-2 (Nakahara et al,
1997; Belien et al, 1999). Wound studies in rats have shown that
during cutaneous wound repair MMP-2 is activated by MT1-
MMP (Okada et al, 1997). As pro-MMP-2 activity was impaired in
MT1-MMP de®cient-mice (Zhou et al, 2000), our limited MT1-
MMP anti-sense results in vitro are consistent with the in vivo
knock-out results. Our control studies showed no difference in
pro-MMP-9 activity following MT1-as expression suggesting that
MT1-MMP plays no part in the pro-MMP-9 activation in human
keratinocytes.
The main role of MT1-MMP, however, is not only to
activate pro-MMP-2, because MMP-2-de®cient mice develop
normally and show little or no impairment of development and
reproduction (Itoh et al, 1997). MMP are involved in tissue
remodeling under various physiologic and pathologic conditions.
MMP-2 is known to facilitate cell invasion in ®broblasts (Okada
et al, 1997; Belien et al, 1999), tumor cells (Sato et al, 1994;
Okada et al, 1995), and endothelial cells by removing matrix
barriers and inducing signaling pathways (Haas et al, 1998;
Koshikawa et al, 2000). Recent studies have demonstrated that
signaling through a4b1 results in an upregulation of MT1-
MMP, which may be a crucial factor in the increased migration
of human mesenchymal cells (Pender et al, 2000). Coordinate
upregulation of MMP-2 and MT1-MMP has also been seen in
skin wound healing (Okada et al, 1997). Our results implicate a
role for MT1-MMP in cell migration in NHK, NIK, and
SCC-25 cells as we observed signi®cant decreases in cell
movement after MT1-as transduction (Fig 5). These changes
were observed in both collagen and ®bronectin, but it is
unclear whether or not they were directly related changes in
MT1-MMP expression, as the loss of normal cellular functions
as a result of a MT1-as expression must be interpreted with
care.
Several possible mechanisms may be responsible for our observ-
ations. The effects of persistent anti-sense MT1-MMP gene
expression via retroviral expression appeared to cause dysfunctional
endogenous regulation of cell surface MT1-MMP that was
maximal at 48±72 h following transduction. We exploited this
apparent blockade of endogenous MT1-MMP expression long
enough to perform functional studies of cellular MMP metabolism
(Fig 4) and cellular responses (Figs 5 and 6) within this 48±72 h
window; however, it is possible that a nonspeci®c effect of anti-
sense cDNA expression (Hertl et al, 1995; Jansen et al, 1995;
Qin et al, 1997; Rockwell et al, 1997; Holmes-Son et al,
2001) may induce decreased cell movement and cell survival, as
we did not express an anti-sense cDNA other than MT1-MMP in
our control experiments. The fact that several speci®c changes in
MMP metabolism were observed in anti-sense, but not sense or
mock-transduced control human microvascular endothelial cells
(Fig 2) nor in control protein expression levels (b-actin, Fig 1C;
TIMP-1, TIMP-2, MMP-2, MMP-9, data not shown) argues
against an indirect or nonspeci®c effect of anti-sense DNA
expression.
Although a direct relation between programmed cell death and
MT1-MMP expression/activity has not been previously reported,
there is growing evidence that MMP metabolism and speci®c
apoptotic signaling pathways are interrelated (Cowan et al, 2000;
Turck et al, 1996; Kondraganti et al, 2000; Koshikawa et al, 2000;
Shamamian et al, 2000; Iida et al, 2001). We showed decreased
cellular survival and increased apoptotic nuclear fragmentation in
anti-sense-transduced NHK, NIK, and SCC-25 cells (Fig 6). It is
possible that the altered cell invasion properties that we observed in
anti-sense MT1-MMP-transduced cells may relate to an indirect
effect on cell survival; however, our protocol is normalized for cell
number and the same number of live cells (48 and 72 h after
transduction) initially adhere and migrate in Boyden chamber
devices. It is only 24 h after plating live cells that we observe
differences in migration between cells transduced with anti-sense
and control cDNA. Furthermore, the magnitude of differences
observed between anti-sense and controls in the cell migration
assays and cell survival assays were different (Figs 5 and 6). Thus,
we believe that the loss of MT1-MMP results in decreased cell
movement based on either its direct effect on matrix metabolism
(Pei and Weiss, 1996; Ohuchi et al, 1997; Nagase and Woessner,
1999) and/or its indirect effects on pro-MMP-2 activation.
Alternatively, as integrin function has been linked to MT1-MMP
activity (Brooks et al, 1996, 1998; Pender et al, 2000), it is possible
that cell±matrix interactions are dysregulated by loss of MT1-MMP
on human keratinocytes.
In summary, we have demonstrated that MT1-MMP may be
involved in keratinocyte migration and survival. It is unknown at
this point if MT1-MMP inhibition directly contributes to these
cellular events, or if it acts by regulating cell±ECM interaction via
pro-MMP2 activation and/or integrin function. Current thera-
peutic approaches targeting MMP activity utilize MMP inhibitors
that are selective but not speci®c and cutaneous delivery of anti-
sense MT1-MMP could provide a novel approach to inhibit MT1-
MMP expression speci®cally in human skin model systems.
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